CombiMatrix to Participate in the RedChip Emerging Growth Showcase
17 January 2014 - 10:00PM
CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics
company specializing in DNA-based testing services for
developmental disorders and cancer diagnostics, today announced
that CEO Mark McDonough is scheduled to participate in the RedChip
Emerging Growth Showcase at 2:00 pm EST on Thursday, January 23,
2014, at www.redchip.com. The showcase, a digital conference, is
being held January 22-23, 2014.
To view the presentation via CombiMatrix's website, go to
www.combimatrix.com in the Investor/Events section
(http://investor.combimatrix.com/events.cfm). A replay of the
webcast will be available for 30 days at the site after the
presentation.
About CombiMatrix Corporation
CombiMatrix Corporation provides valuable molecular diagnostic
solutions and comprehensive clinical support for the highest
quality of care – specializing in miscarriage analysis, prenatal
and pediatric healthcare. CombiMatrix offers comprehensive testing
services for the detection of genetic abnormalities at the DNA
level, beyond what can be identified through traditional
methodologies. The Company performs genetic testing utilizing
advanced technologies, including microarray, FISH, PCR and G-Band
chromosome analyses. Additional information about CombiMatrix is
available at www.combimatrix.com or by calling 1-800-710-0624.
CONTACT: Company Contact:
Mark McDonough
President & CEO, CombiMatrix Corporation
Tel (949) 753-0624
Investor Contact:
Matt Clawson
Partner
Allen & Caron
Tel (949) 474-4399
Matt@allencaron.com
Media Contact:
Len Hall
VP, Media Relations
Allen & Caron
Tel (949) 474-4300
len@allencaron.com
Combimatrix Corp. (MM) (NASDAQ:CBMX)
Historical Stock Chart
From Jul 2024 to Aug 2024
Combimatrix Corp. (MM) (NASDAQ:CBMX)
Historical Stock Chart
From Aug 2023 to Aug 2024
Real-Time news about Combimatrix Corp. (MM) (NASDAQ): 0 recent articles
More News Articles